CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $659 | -95.6% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $15,000 | -37.5% | 12,500 | -5.0% | 0.01% | -40.0% |
| Q2 2022 | $24,000 | +84.6% | 13,153 | +97.7% | 0.02% | +150.0% |
| Q1 2022 | $13,000 | -27.8% | 6,653 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $18,000 | -40.0% | 6,653 | 0.0% | 0.01% | -52.6% |
| Q3 2021 | $30,000 | +66.7% | 6,653 | +111.0% | 0.02% | +72.7% |
| Q2 2021 | $18,000 | -18.2% | 3,153 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $22,000 | +214.3% | 3,153 | +110.2% | 0.02% | +166.7% |
| Q4 2020 | $7,000 | -22.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $9,000 | – | 1,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $18,097,419,000 | 17.62% |
| Boxer Capital, LLC | 850,000 | $37,757,000 | 14.60% |
| Consonance Capital Management LP | 2,730,887 | $121,306,000 | 13.32% |
| Palo Alto Investors LP | 3,804,088 | $168,978,000 | 9.64% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 298,982 | $13,281,000 | 8.01% |
| Redmile Group, LLC | 1,620,355 | $71,976,000 | 6.20% |
| Crosspoint Capital Strategies, LLC | 84,076 | $3,735,000 | 3.32% |
| Ghost Tree Capital, LLC | 220,000 | $9,772,000 | 2.35% |
| PointState Capital LP | 3,171,978 | $140,899,000 | 2.03% |
| NEA Management Company, LLC | 1,139,890 | $50,634,000 | 2.01% |